Significant reduction in blood loss in patients undergoing minimal extracorporeal circulation

W B Gerritsen1, W J van Boven, R M Wesselink

  • 1Department of Clinical Chemistry, St Antonius Hospital, Nieuwegein, The Netherlands. w.gerritsen@antonius.net

Insights

The mini-extracorporeal circuit technique for coronary artery bypass grafting (CABG) resulted in less blood loss and fewer blood product transfusions compared to conventional or off-pump CABG. This suggests improved patient outcomes with the mini-extracorporeal approach.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery

Background:

  • Coronary artery bypass grafting (CABG) techniques, including on-pump and off-pump, have shown varying blood loss and transfusion rates.
  • Mini-extracorporeal circulation (MECC) was developed to mitigate extracorporeal circulation side effects.

Purpose of the Study:

  • To compare blood loss and transfusion requirements among three CABG techniques: off-pump CABG (OPCAB), conventional CABG with cold cardioplegia (CCABG), and MECC with warm blood cardioplegia (MCABG).

Main Methods:

  • A retrospective analysis of 285 first-time CABG patients matched for grafts, age, and sex.
  • Patients were grouped into OPCAB (n=95), CCABG (n=97), and MCABG (n=93).
  • Blood loss and allogeneic transfusion requirements were compared across the three groups.

Main Results:

  • MCABG group showed significantly less blood loss (679 +/- 290 mL) compared to CCABG (819 +/- 557 mL) and OPCAB (870 +/- 768 mL).
  • MCABG patients required significantly fewer red blood cell units than CCABG and OPCAB groups.
  • Platelet concentrate use was significantly lower in the MCABG group compared to the CCABG group on the day of operation.

Conclusions:

  • The mini-extracorporeal circuit technique is associated with reduced blood loss and transfusion needs in CABG surgery.
  • Improvements in MECC technology contribute to decreased utilization of blood products.
  • The study did not confirm the expectation of reduced transfusion needs when the heart-lung machine was entirely avoided (OPCAB).

Related Concept Videos

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...